Loading...

IRWD IRONWOOD PHARMACEUTICALS INC US FDA Inspections 8-K Filing

RNWD

RWD

IRONWOOD PHARMACEUTICALS INC

(IRWD)

2025 8-K

Price Announcement

Business Update

Director Resignation

Compliance Regained

Earnings Releases

Dismissal of Independent Re...

Notice of Delisting

Financial Statements

Financial Statements

Strategic Alternatives

Earnings Update

Workforce Reduction

Management Change

Management Change

Earnings Update

Credit Agreement Update

Financial Update

Annual Meeting Voting Results

Appointment, Repayment of C...

Financial Update

Earnings Reports

Press Release and Corporate...

Earnings Reports

Earnings Reports

Completion of Acquisition

Annual Meeting Approval

Acquisition Agreement

Earnings Reports

Departure of Directors or C...

Financial Update

Earnings Reports

External Links:

On November 25, 2025, Ironwood Pharmaceuticals announced that the Maximum Fair Price for LINZESS is set at $136 for a 30-day supply, effective January 1, 2027, aligning with company expectations.

AI Assistant

IRONWOOD PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.